Elfont R M, Fitzsimons J T
J Physiol. 1983 Oct;343:17-30. doi: 10.1113/jphysiol.1983.sp014879.
In experiments lasting 8 h, low (0.5 mg kg-1) or medium (5 mg kg-1) subcutaneous doses of the angiotensin-converting enzyme inhibitor captopril were mildly dipsogenic in sham-operated rats, much more so in rats subjected to bilateral ureteric ligation and not at all in bilaterally nephrectomized rats. Rats with ligated ureters drank enough water to gain weight during the experiments. All other groups lost weight. The enhanced responsiveness of rats with ligated ureters, despite fluid retention, shows that captopril-induced drinking was not secondary to increased renal fluid loss. Ureteric ligation alone which caused some increase in renin secretion was mildly dipsogenic compared with sham operation. Captopril caused further increases in plasma renin concentration and more drinking suggesting that the captopril response is renin-dependent. The failure of the nephrectomized rat to drink after captopril also shows that the response is renin-dependent. The highest dose (50 mg kg-1) of captopril did not at first stimulate drinking, though water intake increased later. Slowness to drink was not the result of general depression of behaviour since drinking in response to subcutaneous hypertonic NaCl or intracranial angiotensin II was not inhibited by the highest dose. Slowness to drink after the highest dose was attributable to blockade of converting enzyme centrally as well as peripherally. This meant that the increased circulating angiotensin I resulting from peripheral blockade of converting enzyme was only slowly converted to angiotensin II in the brain. When cerebral conversion of angiotensin I was prevented by a single intracranial injection of 25 micrograms captopril, drinking in response to the lower doses of captopril was also inhibited in normal rats and in rats with ligated ureters. The same intracranial dose of captopril also inhibited drinking in response to intracranial injections of renin or angiotensin I, but not angiotensin II. The time course of inhibition of renin-induced drinking was similar to that of inhibition of subcutaneous captopril-induced drinking. In conclusion, subcutaneous captopril causes increased water intake through activation of the renal renin-angiotensin system, an effect that is enhanced when the system has already been partly activated by ureteric ligation. Increased circulating angiotensin I resulting from blockade of peripheral converting enzyme must be converted to angiotensin II in the brain in order to stimulate drinking. Drinking is not the consequence of increased fluid loss.
在持续8小时的实验中,皮下注射低剂量(0.5毫克/千克)或中等剂量(5毫克/千克)的血管紧张素转换酶抑制剂卡托普利,对假手术大鼠有轻度的致渴作用,对双侧输尿管结扎的大鼠致渴作用更强,而对双侧肾切除的大鼠则完全没有致渴作用。输尿管结扎的大鼠在实验期间饮水足够,体重增加。所有其他组体重减轻。尽管输尿管结扎的大鼠有液体潴留,但其反应性增强,这表明卡托普利引起的饮水并非继发于肾液体丢失增加。单独的输尿管结扎会导致肾素分泌略有增加,与假手术相比有轻度的致渴作用。卡托普利使血浆肾素浓度进一步升高,饮水更多,这表明卡托普利的反应是依赖肾素的。肾切除的大鼠在注射卡托普利后不饮水,这也表明该反应是依赖肾素的。卡托普利的最高剂量(50毫克/千克)起初并未刺激饮水,不过后来饮水量增加。饮水缓慢并非行为普遍抑制的结果,因为皮下注射高渗氯化钠或脑室内注射血管紧张素II引起的饮水并未受到最高剂量的抑制。最高剂量后饮水缓慢归因于中枢和外周转化酶的阻断。这意味着外周转化酶阻断导致循环中的血管紧张素I增加,在脑中只能缓慢转化为血管紧张素II。当通过脑室内单次注射25微克卡托普利阻止血管紧张素I在脑内的转化时,正常大鼠和输尿管结扎的大鼠对较低剂量卡托普利的饮水反应也受到抑制。相同脑室内剂量的卡托普利也抑制对脑室内注射肾素或血管紧张素I的饮水反应,但不抑制对血管紧张素II的反应。抑制肾素诱导饮水的时间进程与抑制皮下注射卡托普利诱导饮水的时间进程相似。总之,皮下注射卡托普利通过激活肾素 - 血管紧张素系统导致饮水量增加,当该系统已被输尿管结扎部分激活时,这种作用会增强。外周转化酶阻断导致循环中的血管紧张素I增加,必须在脑内转化为血管紧张素II才能刺激饮水。饮水并非液体丢失增加的结果。